The New England journal of medicine, 2018-06, Vol.378 (23), p.2191-2201
- Hart, Robert G
- Sharma, Mukul
- Mundl, Hardi
- Kasner, Scott E
- Bangdiwala, Shrikant I
- Berkowitz, Scott D
- Swaminathan, Balakumar
- Lavados, Pablo
- Wang, Yongjun
- Wang, Yilong
- Davalos, Antonio
- Shamalov, Nikolay
- Mikulik, Robert
- Cunha, Luis
- Lindgren, Arne
- Arauz, Antonio
- Lang, Wilfried
- Czlonkowska, Anna
- Eckstein, Jens
- Gagliardi, Rubens J
- Amarenco, Pierre
- Ameriso, Sebastian F
- Tatlisumak, Turgut
- Veltkamp, Roland
- Hankey, Graeme J
- Toni, Danilo
- Bereczki, Daniel
- Uchiyama, Shinichiro
- Ntaios, George
- Yoon, Byung-Woo
- Brouns, Raf
- Endres, Matthias
- Muir, Keith W
- Bornstein, Natan
- Ozturk, Serefnur
- O’Donnell, Martin J
- De Vries Basson, Matthys M
- Pare, Guillaume
- Pater, Calin
- Kirsch, Bodo
- Sheridan, Patrick
- Peters, Gary
- Weitz, Jeffrey I
- Peacock, W. Frank
- Shoamanesh, Ashkan
- Benavente, Oscar R
- Joyner, Campbell
- Themeles, Ellison
- Connolly, Stuart J
2018
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Hart, Robert G
- Sharma, Mukul
- Mundl, Hardi
- Kasner, Scott E
- Bangdiwala, Shrikant I
- Berkowitz, Scott D
- Swaminathan, Balakumar
- Lavados, Pablo
- Wang, Yongjun
- Wang, Yilong
- Davalos, Antonio
- Shamalov, Nikolay
- Mikulik, Robert
- Cunha, Luis
- Lindgren, Arne
- Arauz, Antonio
- Lang, Wilfried
- Czlonkowska, Anna
- Eckstein, Jens
- Gagliardi, Rubens J
- Amarenco, Pierre
- Ameriso, Sebastian F
- Tatlisumak, Turgut
- Veltkamp, Roland
- Hankey, Graeme J
- Toni, Danilo
- Bereczki, Daniel
- Uchiyama, Shinichiro
- Ntaios, George
- Yoon, Byung-Woo
- Brouns, Raf
- Endres, Matthias
- Muir, Keith W
- Bornstein, Natan
- Ozturk, Serefnur
- O’Donnell, Martin J
- De Vries Basson, Matthys M
- Pare, Guillaume
- Pater, Calin
- Kirsch, Bodo
- Sheridan, Patrick
- Peters, Gary
- Weitz, Jeffrey I
- Peacock, W. Frank
- Shoamanesh, Ashkan
- Benavente, Oscar R
- Joyner, Campbell
- Themeles, Ellison
- Connolly, Stuart J
- Titel
- Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
- Ist Teil von
- The New England journal of medicine, 2018-06, Vol.378 (23), p.2191-2201
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2018
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a lower incidence of recurrent stroke than aspirin at a dose of 100 mg. Bleeding rates were higher with rivaroxaban.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa1802686Titel-ID: cdi_swepub_primary_oai_prod_swepub_kib_ki_se_138517833
- Format
- –
- Schlagworte
- Aged, Anticoagulants, antithrombotic therapy, Aspirin, Aspirin - adverse effects, Aspirin - therapeutic use, Atherosclerosis, atrial-fibrillation, Bleeding, Blood clots, Brain Ischemia - prevention & control, Cardiac and Cardiovascular Systems, Cardiac arrhythmia, Clinical Medicine, cryptogenic stroke, Design, Drug dosages, efficacy, Embolism, Embolisms, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - therapeutic use, Female, foramen ovale closure, General & Internal Medicine, Hemorrhage, Hemorrhage - chemically induced, Hospitals, Human health and pathology, Humans, Internal medicine, Intracranial Embolism - drug therapy, Ischemia, Kaplan-Meier Estimate, Kardiologi, Klinisk medicin, Life Sciences, Male, Medical and Health Sciences, Medical research, Medicin och hälsovetenskap, Medicine, metaanalysis, Middle Aged, Neurology, Neurosciences, Patients, Platelet Aggregation Inhibitors - adverse effects, Platelet Aggregation Inhibitors - therapeutic use, Prevention, R&D, Research & development, Research centers, Rivaroxaban - adverse effects, Rivaroxaban - therapeutic use, safety, Secondary Prevention - methods, Stenosis, Stroke, Stroke - etiology, Stroke - prevention & control, Thrombosis, trials, warfarin